Xaira Therapeutics

Private

South San Francisco-based AI-native biotech co-founded by David Baker (Nobel Chemistry 2024). Uses RFdiffusion generative protein design to discover and develop novel therapeutics. Founded 2023.

Founders David Baker, Marc Tessier-Lavigne
CEO Marc Tessier-Lavigne

Company

Founded
2023
Headquarters
South San Francisco, United States

Financials

Total Funding
$1.6B
Sectors
Artificial Intelligence Biotech
xairatherapeutics.com

Funding History

2 rounds
Series B Jul 2, 2026
$550M
ARCH Venture Partners (Lead) Foresite Capital F-Prime Capital NEA Sequoia Capital Lightspeed Venture Partners Menlo Ventures Bezos Expeditions Fidelity Management & Research NVIDIA GV
Series A Apr 23, 2024
$1.0B
ARCH Venture Partners (Lead) Foresite Capital F-Prime Capital NEA Sequoia Capital Lightspeed Venture Partners Menlo Ventures Two Sigma Ventures SV Angel Bezos Expeditions Fidelity Management & Research Rockefeller Foundation Parker Foundation

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.